Evangelia Sereti

Dr. Evangelia Sereti

Lund University, Department of Translational Medicine, Medical Faculty
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Pharmacological Research
Verified
Journal Article
Closed access
BCBuse Cevatemre
Buse Cevatemre
MEMerve Erkısa
Merve Erkısa
NANazlihan Aztopal
Nazlihan Aztopal
Didem KarakasDidem Karakas
Didem Karakas
PAPınar Alper
Pınar Alper
EUEngin Ulukaya
Engin Ulukaya

1 August 2018 in Progress in Polymer Science
Verified
Journal Article
Closed access
ELEvelina Liarou
Evelina Liarou
Spyridon VarlasSpyridon Varlas
Spyridon Varlas
Dimitrios SkoulasDimitrios Skoulas
Dimitrios Skoulas
CTChrisida Tsimblouli
Chrisida Tsimblouli
Evangelia SeretiEvangelia Sereti
Evangelia Sereti
Hermis IatrouHermis Iatrou
Hermis Iatrou

10 August 2018 in Biomacromolecules
Verified
Journal Article
Closed access
PBPanagiotis Bilalis
Panagiotis Bilalis
Dimitrios SkoulasDimitrios Skoulas
Dimitrios Skoulas
AKAnastasios Karatzas
Anastasios Karatzas
JMJohn Marakis
John Marakis
ASAthanasios Stamogiannos
Athanasios Stamogiannos
HIHermis Iatrou
Hermis Iatrou

1 September 2018 in Journal of Proteomics
Verified
Journal Article
Closed access
Evangelia SeretiEvangelia Sereti
Evangelia Sereti
TKTheodosia Karagianellou
Theodosia Karagianellou
IKIoanna Kotsoni
Ioanna Kotsoni
Dimitrios E. MagouliotisDimitrios E. Magouliotis
Dimitrios E. Magouliotis
KKKonstantinos Kamposioras
Konstantinos Kamposioras
Konstantinos DimasKonstantinos Dimas
Konstantinos Dimas

1 April 2021 in Cellular Signalling
Verified
Journal Article
Closed access
ALAndromachi Lambrianidou
Andromachi Lambrianidou
Evangelia SeretiEvangelia Sereti
Evangelia Sereti
KSKaterina Soupsana
Katerina Soupsana
CKChrysoula Komini
Chrysoula Komini
KDKonstantinos Dimas
Konstantinos Dimas
TTTHEONI TRANGAS
THEONI TRANGAS

9 July 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
AYAndreas Yallouris
Andreas Yallouris
IPIoannis Patrikios
Ioannis Patrikios
EJElizabeth O. Johnson
Elizabeth O. Johnson
Evangelia SeretiEvangelia Sereti
Evangelia Sereti
KDKonstantinos Dimas
Konstantinos Dimas
ASAnastasis Stephanou
Anastasis Stephanou
In the healthcare sector, phytocompounds are known to be beneficial by contributing or alleviating a variety of diseases. Studies have demonstrated the progressive effects of phytocompounds on immune-related diseases and to exhibit anticancer effects. Graviola tree is an evergreen tree with its extracts (leafs and seeds) been reported having anticancer properties, but the precise target of action is not clear. Using an in silico approach, we predicted that annonacin, an Acetogenin, the active agent found in Graviola leaf extract (GLE) to potentially act as a novel inhibitor of both sodium/potassium (NKA) and sarcoplasmic reticulum (SERCA) ATPase pumps. We were able to validate and confirm the in silico studies by showing that GLE inhibited NKA and SERCA activity in intact cells. In the present study, we also demonstrated the antiproliferative and anticancer effects of GLE in a variety of cancer cell lines with limited toxic effects on non-transformed cells. Moreover, our results revealed that known inhibitors of both NKA and SERCA pumps could also promote cell death in several cancer cell lines. In addition, a mouse xenograft cancer model showed GLE as able to reduce tumor size and progression. Finally, bioprofiling studies indicated a strong correlation between overexpression of both NKA and SERCA gene expression vs. survival rates. Overall, our results demonstrated that GLE can promote selective cancer cell death via inhibiting NKA and SERCA, and thus can be considered as a potential novel treatment for cancer. After molecular analysis of GLE by liquid chromatography–mass spectrometry and ESI–QTOF–MS analysis, it was found that the MS spectrum of the high abundant chromatographic peak purified sample highly consisted of annonacin.